Direct Radioimmunoassay of 6-Sulfatoxymelatonin in Plasma with Use of an Iodinated Tracer

44Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.
Get full text

Abstract

We describe here a direct radioimmunoassay (RIA) for the determination of 6-sulfatoxymelatonin (aMT6s) in plasma, with iodinated aMT6s as tracer. The aMT6s antiserum was raised in rabbit by immunization with a bovine serum albumin conjugate, giving negligible cross-reactivities for related compounds. The low limit of detection (15 pmol/L) allowed a direct assay that required only a 100-μL plasma sample. Dilutions of plasma and of synthetic aMT6s gave the same parallel response in the RIA. A preliminary study showed a circadian variation in healthy volunteers, with mean concentrations ranging from 52 (at 1600-2100 h) to 378 pmol/L (at 0400 h), whereas this rhythm was abolished in pinealomectomized patients. After administration of melatonin orally, or by infusion, the aMT6s concentrations in plasma concorded with previous data on aMT6s production and pharmacokinetics, with aMT6s being cleared from plasma more slowly than melatonin. This assay should have practical application in the development of new pharmaceutical formulations that minimize the hepatic metabolism of melatonin.

Cite

CITATION STYLE

APA

Harthé, C., Claustrat, B., Brun, J., & Chazot, G. (1991). Direct Radioimmunoassay of 6-Sulfatoxymelatonin in Plasma with Use of an Iodinated Tracer. Clinical Chemistry, 37(4), 536–539. https://doi.org/10.1093/clinchem/37.4.536

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free